Exploratory efficacy results from the TANDEM trial: Safety, tolerability, and efficacy of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine

Authors
Category Primary study
ConferenceAmerican Headache Society 66th Annual Scientific Meeting
Year 2024
This article has no abstract
Epistemonikos ID: cf6f50aa71141d5f95aeb9b1e0825236614ea126
First added on: Jan 07, 2026